Understanding how tiny RNAs can silence genes
Structural and molecular basis for cityRNA (cleavage-inducing tiny RNA)-directed RNA cleavage by AGO3
This study is exploring a new type of tiny RNA that helps control gene activity, and it's aimed at understanding how these tiny molecules work, which could lead to better treatments for people with neurodevelopmental diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-11145098 on NIH RePORTER |
What this research studies
This research investigates a new class of small RNAs called tinyRNAs, which play a crucial role in gene silencing by forming complexes with Argonaute proteins. The study aims to uncover the mechanisms by which these tinyRNAs, particularly cleavage-inducing tinyRNAs (cityRNAs), recognize and cleave target RNA sequences. By employing structural studies and RNA sequencing, the research seeks to provide insights into the unique properties of these tinyRNAs and their potential implications in neurodevelopmental diseases. Patients may benefit from a better understanding of gene regulation and potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with neurodevelopmental disorders or conditions related to gene expression.
Not a fit: Patients with conditions unrelated to RNA regulation or gene silencing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating diseases linked to gene regulation.
How similar studies have performed: While the study of tinyRNAs is relatively novel, previous research on microRNAs has shown significant success in understanding gene regulation.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Nakanishi, Kotaro — Ohio State University
- Study coordinator: Nakanishi, Kotaro
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.